• SPX
  • $5,782.76
  • 1.23 %
  • $70.07
  • DJI
  • $42,221.88
  • 1.02 %
  • $427.28
  • N225
  • $38,780.35
  • 0.79 %
  • $305.67
  • FTSE
  • $8,172.39
  • -0.14 %
  • -$11.85
  • IXIC
  • $18,439.17
  • 1.43 %
  • $259.19
Mineralys Therapeutics, Inc. (MLYS) Insider Traders

Mineralys Therapeutics, Inc. (MLYS) Insider Traders

NASDAQ Currency in USD Disclaimer

Stock Price

$13.49

-$0.01

(-0.07%)

Day's range
$13.35
Day's range
$13.7
  • NUMBER OF INSIDER BUYING

    (Last 12 Months)

    2
  • NUMBER OF INSIDER SELLING

    (Last 12 Months)

    4
  • AMOUNT OF INSIDERS BUYING

    (Last 12 Months)

    $7.53 M
  • AMOUNT OF INSIDERS SELLING

    (Last 12 Months)

    $10.31 M

Mineralys Therapeutics, Inc. Insider Transactions

Mineralys Therapeutics, Inc. Insider Trades History

Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held
After Transaction
Transaction Date Filing Date Details
Slingsby Brian Taylor

Director, 10 percent owner:

Sell 550,000 @ $13.05 $7.18 M 8,644,579 07/24/2024 07/26/2024
Rodman David Malcom

Chief Medical Officer

Sell 525 @ $15.00 $7,876 102,873 07/16/2024 07/18/2024
Levy Adam Scott

CFO and Secretary

Sell 10,757 @ $13.14 $141,394 247,611 07/11/2024 07/12/2024
Sell 15,746 @ $13.34 $210,075 911,212 07/11/2024 07/12/2024
Sell 14,940 @ $11.73 $175,237 926,958 06/20/2024 06/20/2024
Sell 16,607 @ $11.99 $199,073 941,898 06/18/2024 06/20/2024
Sell 17,766 @ $12.25 $217,712 958,505 06/17/2024 06/20/2024
Sell 16,229 @ $12.52 $203,163 976,271 06/14/2024 06/14/2024
Sell 39,961 @ $12.74 $509,027 992,500 06/13/2024 06/14/2024
Sell 16,607 @ $12.77 $212,013 1,032,461 06/12/2024 06/14/2024
Levy Adam Scott

CFO and Secretary

Sell 96,815 @ $12.94 $1.25 M 255,462 06/11/2024 06/13/2024
Rodman David Malcom

Chief Medical Officer

Sell 100 @ $15.00 $1,500 66,997 05/09/2024 05/10/2024
Samsara BioCapital GP, LLC

10 percent owner

Buy 555,555 @ $13.50 $7.50 M 5,074,916 02/12/2024 02/14/2024
Buy 4,250 @ $5.97 $25,356 1,049,068 11/22/2023 11/27/2023
Buy 2,250 @ $12.08 $27,180 1,044,818 09/06/2023 09/08/2023
Buy 2,250 @ $12.10 $27,225 1,042,568 08/17/2023 08/21/2023
Rodman David Malcom

Chief Medical Officer

Sell 76,182 @ $12.81 $975,891 0 08/11/2023 08/11/2023
Buy 2,000 @ $12.89 $25,780 1,040,318 08/11/2023 08/11/2023
Rodman David Malcom

Chief Medical Officer

Sell 74,625 @ $13.16 $982,065 0 08/10/2023 08/11/2023
Buy 312,500 @ $16.00 $5.00 M 3,218,106 02/14/2023 02/16/2023

Mineralys Therapeutics, Inc. Frequently Asked Questions

  • Who is on Mineralys Therapeutics, Inc.'s Insider Roster?

    The list of insiders at Mineralys Therapeutics, Inc. includes Congleton Jon, Samsara BioCapital GP, LLC, Rodman David Malcom, Levy Adam Scott, Slingsby Brian Taylor.

  • How much insider selling is happening at Mineralys Therapeutics, Inc.?

    Insiders have sold a total of 796,053 Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 10.31 M sold.

  • Which Mineralys Therapeutics, Inc. insiders have been selling company stock?

    The following insiders have sold Mineralys Therapeutics, Inc. shares in the last 12 months: Rodman David Malcom ($9,376), Levy Adam Scott ($1.39 M), Congleton Jon ($1.73 M), Slingsby Brian Taylor ($7.18 M),

  • How much insider buying is happening at Mineralys Therapeutics, Inc.?

    Insiders have purchased a total of 559,805 Mineralys Therapeutics, Inc. shares in the last 12 months for a total of 7.53 M sold.

  • Which Mineralys Therapeutics, Inc. insiders have been buying company stock?

    The following insiders have purchased Mineralys Therapeutics, Inc. shares in the last 12 months: Congleton Jon ($25,356), Samsara BioCapital GP, LLC ($7.50 M),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.